Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Repligen Corp (NASDAQ: RGEN) closed at $126.19 down -0.25% from its previous closing price of $126.50. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 0.87 million shares were traded.
Ratios:
For a deeper understanding of Repligen Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.21. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 6.79. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.34.
On March 18, 2025, Evercore ISI started tracking the stock assigning a In-line rating and target price of $155.
On February 10, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $200.TD Cowen initiated its Buy rating on February 10, 2025, with a $200 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 15 ’25 when Hunt Anthony sold 26,447 shares for $123.71 per share. The transaction valued at 3,271,688 led to the insider holds 109,854 shares of the business.
Hunt Anthony bought 26,447 shares of RGEN for $3,394,208 on May 15 ’25. On Mar 17 ’25, another insider, Hunt Anthony, who serves as the Director of the company, sold 26,756 shares for $152.51 each. As a result, the insider received 4,080,663 and left with 136,301 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.90 while its Price-to-Book (P/B) ratio in mrq is 3.57.
Stock Price History:
Over the past 52 weeks, RGEN has reached a high of $182.52, while it has fallen to a 52-week low of $102.96. The 50-Day Moving Average of the stock is -5.61%, while the 200-Day Moving Average is calculated to be -13.37%.
Shares Statistics:
A total of 56.18M shares are outstanding, with a floating share count of 53.13M. Insiders hold about 5.44% of the company’s shares, while institutions hold 102.41% stake in the company.
Earnings Estimates
The market rating for Repligen Corp (RGEN) is a result of the insights provided by 15.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.39, with high estimates of $0.42 and low estimates of $0.33.
Analysts are recommending an EPS of between $1.74 and $1.64 for the fiscal current year, implying an average EPS of $1.68. EPS for the following year is $2.17, with 16.0 analysts recommending between $2.3 and $1.78.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $174.62M this quarter.It ranges from a high estimate of $179.1M to a low estimate of $168.8M. As of the current estimate, Repligen Corp’s year-ago sales were $154.07MFor the next quarter, 17 analysts are estimating revenue of $174.98M. There is a high estimate of $180.03M for the next quarter, whereas the lowest estimate is $169.95M.
A total of 19 analysts have provided revenue estimates for RGEN’s current fiscal year. The highest revenue estimate was $714.5M, while the lowest revenue estimate was $697.22M, resulting in an average revenue estimate of $708.66M. In the same quarter a year ago, actual revenue was $634.44MBased on 18 analysts’ estimates, the company’s revenue will be $810.38M in the next fiscal year. The high estimate is $842.1M and the low estimate is $785M.
